Alexandria Venture Investments, LLC - 01 Jun 2021 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
10%+ Owner
Signature
By: ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member By: /s/ Dean A. Shigenaga Chief Financial Officer
Issuer symbol
N/A
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
01 Jun 2021, 17:22:47 UTC
Previous filing
26 May 2021
Next filing
21 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common stock Conversion of derivative security $0 +2,645,985 $0.000000 2,645,985 01 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Series A convertible preferred stock Conversion of derivative security -1,796,684 -100% 0 01 Jun 2021 Common stock 1,796,684 Direct F1, F2
transaction OMIC Series B convertible preferred stock Conversion of derivative security -849,301 -100% 0 01 Jun 2021 Common stock 849,301 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Alexandria Venture Investments, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each share of preferred stock automatically converted into the Issuer's common stock at a ratio of 1 share of preferred stock to 1 share of common stock upon closing of the Issuer's initial public offering on May 26, 2021, for no additional consideration. The shares had no expiration date.
F2 Not applicable.